Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-16 Sale |
2024-01-17 4:45 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
864 | $66.81 | $57,723 | 52,214 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:43 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
1,632 | $66.81 | $109,032 | 81,603 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:41 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,631 | $66.81 | $108,965 | 91,620 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
1,857 | $66.81 | $124,064 | 99,302 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
4,240 | $66.81 | $283,268 | 234,499 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
2,235 | $66.81 | $149,317 | 132,453 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
2,235 | $66.81 | $149,317 | 189,991 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:32 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
7,851 | $66.81 | $524,514 | 2,160,300 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 12:24 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
438 | $66.81 | $29,262 | 101,017 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
2,751 | $60.05 | $165,207 | 32,931 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-28 4:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
303 | $59.7 | $18,089 | 53,580 (Direct) |
View |
| 2023-12-19 Sale |
2023-12-20 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
3,905 | $57.23 | $223,472 | 184,220 (Indirect Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 7:40 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
10,000 | $60 | $600,000 | 107,690 (Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 7:29 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
110,000 | $60.81 | $6,689,303 | 248,907 (Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 4:21 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
24,000 | $61.13 | $1,467,240 | 346,937 (Indirect Direct) |
View |
| 2023-11-30 Sale |
2023-12-01 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,158 | $54.73 | $774,884 | 401,848 (Indirect Direct) |
View |
| 2023-11-21 Sale |
2023-11-21 5:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
5,000 | $48.8 | $244,000 | 1,991,223 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-21 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
8,894 | $49.99 | $444,620 | 370,937 (Indirect Direct) |
View |
| 2023-10-17 Sale |
2023-11-21 4:00 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
24,000 | $49 | $1,176,000 | 379,831 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $47.74 | $59,675 | 779,370 (Indirect Direct) |
View |
| 2023-11-08 Sale |
2023-11-09 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $47.27 | $567,240 | 1,071,807 (Direct) |
View |
| 2023-10-23 Sale |
2023-10-24 4:20 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
132 | $46.04 | $6,077 | 32,680 (Direct) |
View |
| 2023-10-23 Sale |
2023-10-24 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
131 | $46.04 | $6,031 | 51,622 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-18 5:43 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $48.5 | $60,625 | 780,620 (Indirect Direct) |
View |
| 2023-10-09 Sale |
2023-10-10 4:26 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $40.38 | $484,560 | 1,083,807 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-19 5:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $45 | $56,250 | 781,870 (Indirect Direct) |
View |
| 2023-09-18 Sale |
2023-09-19 5:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
20,350 | $44.27 | $900,813 | 168,565 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-18 4:24 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $45.34 | $56,675 | 783,120 (Indirect Direct) |
View |
| 2023-09-08 Sale |
2023-09-11 4:58 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $42.87 | $514,440 | 1,095,807 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-07 4:08 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
1,756 | $43.01 | $75,526 | 68,299 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-16 Option Award |
2024-01-17 4:45 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
8,312 | $0 | 52,214 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:45 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
12,086 | $66.3 | 52,214 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:43 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
16,963 | $0 | 81,603 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:43 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
24,666 | $66.3 | 81,603 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:41 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
16,963 | $0 | 91,620 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:41 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
24,666 | $66.3 | 91,620 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
19,508 | $0 | 99,302 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:40 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
28,367 | $66.3 | 99,302 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:38 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
23,748 | $0 | 234,499 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:38 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
34,533 | $66.3 | 234,499 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:37 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
23,748 | $0 | 132,453 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:37 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
34,533 | $66.3 | 132,453 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:36 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
23,748 | $0 | 189,991 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:36 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
34,533 | $66.3 | 189,991 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:33 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
25,445 | $0 | 95,376 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:33 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
37,000 | $66.3 | 95,376 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
72,094 | $0 | 2,160,300 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:32 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
104,834 | $66.3 | 2,160,300 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 12:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
19,508 | $0 | 101,017 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 12:24 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
28,367 | $66.3 | 101,017 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
3,341 | $0 | 22,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:13 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
5,748 | $59.86 | 22,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
3,341 | $0 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:12 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
5,748 | $59.86 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
3,341 | $0 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:10 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
5,748 | $59.86 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
3,341 | $0 | 362,300 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:09 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
5,748 | $59.86 | 362,300 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
3,341 | $0 | 788,459 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:08 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
5,748 | $59.86 | 788,459 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-20 4:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
7,905 | $13.85 | 184,220 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-20 4:18 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
7,905 | $0 | 184,220 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-15 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,274 | $13.19 | 360,211 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-15 4:04 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,274 | $0 | 360,211 (Direct) |
View |
| 2023-12-01 Exercise |
2023-12-05 7:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
10,000 | $13.85 | 107,690 (Direct) |
View |
| 2023-12-01 Exercise |
2023-12-05 7:40 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS Chief Research Officer |
10,000 | $0 | 107,690 (Direct) |
View |
| 2023-12-01 Exercise |
2023-12-05 7:29 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
110,000 | $0 | 248,907 (Direct) |
View |
| 2023-12-01 Exercise |
2023-12-05 7:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
110,000 | $15.09 | 248,907 (Direct) |
View |
| 2023-11-30 Exercise |
2023-12-01 4:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,158 | $10.03 | 401,848 (Direct) |
View |
| 2023-11-30 Exercise |
2023-12-01 4:11 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,158 | $0 | 401,848 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-20 4:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 779,370 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-20 4:18 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 779,370 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-15 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
45,000 | $3.76 | 1,292,301 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-15 4:10 pm |
N/A 2026-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
45,000 | $0 | 1,292,301 (Direct) |
View |
| 2023-11-08 Exercise |
2023-11-09 4:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
17,494 | $2.67 | 1,071,807 (Direct) |
View |
| 2023-11-08 Exercise |
2023-11-09 4:18 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
17,494 | $0 | 1,071,807 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-18 5:43 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 780,620 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-18 5:43 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 780,620 (Direct) |
View |
| 2023-10-09 Exercise |
2023-10-10 4:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,083,807 (Direct) |
View |
| 2023-10-09 Exercise |
2023-10-10 4:26 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,083,807 (Direct) |
View |
| 2023-09-19 Gift |
2023-09-20 4:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
150,000 | $0 | 1,996,223 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-19 5:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 781,870 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-19 5:05 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 781,870 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-19 5:03 pm |
N/A 2030-08-16 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
9,719 | $0 | 168,565 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-19 5:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
9,719 | $29.76 | 168,565 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-18 4:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 783,120 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-18 4:24 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 783,120 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
2,500 | $0 | 32,812 (Direct) |
View |
| 2023-09-08 Exercise |
2023-09-11 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,095,807 (Direct) |
View |
| 2023-09-08 Exercise |
2023-09-11 4:58 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,095,807 (Direct) |
View |